Clinical-stage biotech developing personalized iPSC-derived autologous cell therapies for Parkinson's disease.
Get notified the moment Aspen Neuroscience files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.